3.連結財務諸表及び主な注記
(1)連結貸借対照表
|
|
|
|
|
|
|
|
|
|
|
|
(単位:百万円)
|
|
|
|
|
|
|
|
|
|
|
|
前連結会計年度
(2024年3月31日)
|
当連結会計年度
(2025年3月31日)
|
|
資産の部
|
|
|
|
|
流動資産
|
|
|
|
|
|
現金及び預金
|
99,667
|
106,668
|
|
|
|
受取手形及び売掛金
|
160,240
|
166,858
|
|
|
|
契約資産
|
-
|
226
|
|
|
|
商品及び製品
|
150,391
|
170,857
|
|
|
|
仕掛品
|
20,757
|
21,105
|
|
|
|
原材料及び貯蔵品
|
55,915
|
59,149
|
|
|
|
その他
|
42,555
|
56,317
|
|
|
|
貸倒引当金
|
△5,362
|
△6,764
|
|
|
|
流動資産合計
|
524,166
|
574,418
|
|
|
固定資産
|
|
|
|
|
|
有形固定資産
|
|
|
|
|
|
|
建物及び構築物
|
337,409
|
350,245
|
|
|
|
|
|
減価償却累計額及び減損損失累計額
|
△156,680
|
△171,399
|
|
|
|
|
|
建物及び構築物(純額)
|
180,729
|
178,845
|
|
|
|
|
機械装置及び運搬具
|
408,015
|
459,621
|
|
|
|
|
|
減価償却累計額及び減損損失累計額
|
△288,780
|
△326,411
|
|
|
|
|
|
機械装置及び運搬具(純額)
|
119,235
|
133,210
|
|
|
|
|
土地
|
47,061
|
48,288
|
|
|
|
|
リース資産
|
40,149
|
45,298
|
|
|
|
|
|
減価償却累計額
|
△16,778
|
△20,679
|
|
|
|
|
|
リース資産(純額)
|
23,371
|
24,619
|
|
|
|
|
建設仮勘定
|
83,284
|
88,975
|
|
|
|
|
その他
|
101,983
|
113,597
|
|
|
|
|
|
減価償却累計額及び減損損失累計額
|
△74,156
|
△83,709
|
|
|
|
|
|
その他(純額)
|
27,826
|
29,887
|
|
|
|
|
有形固定資産合計
|
481,508
|
503,827
|
|
|
|
無形固定資産
|
|
|
|
|
|
|
のれん
|
15,607
|
14,099
|
|
|
|
|
リース資産
|
1,921
|
1,880
|
|
|
|
|
その他
|
17,609
|
19,525
|
|
|
|
|
無形固定資産合計
|
35,138
|
35,505
|
|
|
|
投資その他の資産
|
|
|
|
|
|
|
投資有価証券
|
32,945
|
15,287
|
|
|
|
|
退職給付に係る資産
|
94
|
2,278
|
|
|
|
|
繰延税金資産
|
13,116
|
17,216
|
|
|
|
|
その他
|
29,990
|
27,842
|
|
|
|
|
貸倒引当金
|
△7,139
|
△5,814
|
|
|
|
|
投資その他の資産合計
|
69,007
|
56,812
|
|
|
|
固定資産合計
|
585,655
|
596,145
|
|
|
資産合計
|
1,109,821
|
1,170,564
|
|
|
|
|
|
|
|
|
|
|
|
|
(単位:百万円)
|
|
|
|
|
|
|
|
|
|
|
|
前連結会計年度
(2024年3月31日)
|
当連結会計年度
(2025年3月31日)
|
|
負債の部
|
|
|
|
|
流動負債
|
|
|
|
|
|
支払手形及び買掛金
|
81,502
|
83,802
|
|
|
|
短期借入金
|
160,367
|
156,174
|
|
|
|
コマーシャル・ペーパー
|
20,000
|
-
|
|
|
|
1年内償還予定の社債
|
4,700
|
1,000
|
|
|
|
リース債務
|
4,748
|
6,653
|
|
|
|
未払金
|
25,837
|
30,979
|
|
|
|
未払法人税等
|
6,125
|
5,922
|
|
|
|
契約負債
|
714
|
1,035
|
|
|
|
賞与引当金
|
11,436
|
9,058
|
|
|
|
設備関係支払手形
|
5,591
|
4,799
|
|
|
|
その他
|
45,451
|
51,119
|
|
|
|
流動負債合計
|
366,475
|
350,545
|
|
|
固定負債
|
|
|
|
|
|
社債
|
82,000
|
103,000
|
|
|
|
転換社債型新株予約権付社債
|
30,150
|
30,090
|
|
|
|
長期借入金
|
302,819
|
309,987
|
|
|
|
リース債務
|
25,312
|
25,170
|
|
|
|
繰延税金負債
|
1,619
|
2,018
|
|
|
|
退職給付に係る負債
|
5,675
|
7,244
|
|
|
|
役員退職慰労引当金
|
557
|
584
|
|
|
|
訴訟損失引当金
|
227
|
276
|
|
|
|
その他
|
25,195
|
30,024
|
|
|
|
固定負債合計
|
473,557
|
508,397
|
|
|
負債合計
|
840,032
|
858,942
|
|
純資産の部
|
|
|
|
|
株主資本
|
|
|
|
|
|
資本金
|
84,397
|
84,397
|
|
|
|
資本剰余金
|
0
|
-
|
|
|
|
利益剰余金
|
104,321
|
104,783
|
|
|
|
自己株式
|
△10,749
|
△10,749
|
|
|
|
株主資本合計
|
177,970
|
178,431
|
|
|
その他の包括利益累計額
|
|
|
|
|
|
その他有価証券評価差額金
|
9,704
|
2,741
|
|
|
|
繰延ヘッジ損益
|
△50
|
176
|
|
|
|
為替換算調整勘定
|
43,516
|
68,920
|
|
|
|
退職給付に係る調整累計額
|
1,524
|
2,172
|
|
|
|
その他の包括利益累計額合計
|
54,695
|
74,010
|
|
|
新株予約権
|
-
|
4
|
|
|
非支配株主持分
|
37,123
|
59,175
|
|
|
純資産合計
|
269,788
|
311,621
|
|
負債純資産合計
|
1,109,821
|
1,170,564
|
E02688
80860
ニプロ株式会社
NIPRO CORPORATION
通期第1号参考様式 [日本基準](連結)
Japan GAAP
true
cte
cte
2024-04-01
2025-03-31
FY
2025-03-31
2023-04-01
2024-03-31
2024-03-31
1
false
false
false
80860
2025-05-12
80860
2024-04-01
2025-03-31
80860
2024-04-01
2025-03-31
jppfs_cor:CapitalStockMember
80860
2024-04-01
2025-03-31
jppfs_cor:CapitalSurplusMember
80860
2024-04-01
2025-03-31
jppfs_cor:DeferredGainsOrLossesOnHedgesMember
80860
2024-04-01
2025-03-31
jppfs_cor:ForeignCurrencyTranslationAdjustmentMember
80860
2024-04-01
2025-03-31
jppfs_cor:NonControllingInterestsMember
80860
2024-04-01
2025-03-31
jpcrp_cor:OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember
80860
2024-04-01
2025-03-31
jpcrp_cor:ReconcilingItemsMember
80860
2024-04-01
2025-03-31
jppfs_cor:RemeasurementsOfDefinedBenefitPlansMember
80860
2024-04-01
2025-03-31
jpcrp_cor:ReportableSegmentsMember
80860
2024-04-01
2025-03-31
jppfs_cor:RetainedEarningsMember
80860
2024-04-01
2025-03-31
jppfs_cor:ShareholdersEquityMember
80860
2024-04-01
2025-03-31
jppfs_cor:SubscriptionRightsToSharesMember
80860
2024-04-01
2025-03-31
jpcrp_cor:TotalOfReportableSegmentsAndOthersMember
80860
2024-04-01
2025-03-31
jppfs_cor:TreasuryStockMember
80860
2024-04-01
2025-03-31
tse-acedjpfr-80860:MedicalTreatmentRelatedReportableSegmentsMember
80860
2024-04-01
2025-03-31
tse-acedjpfr-80860:MedicineRelatedReportableSegmentsMember
80860
2024-04-01
2025-03-31
tse-acedjpfr-80860:PharmaPackagingReportableSegmentMember
80860
2024-04-01
2025-03-31
jppfs_cor:ValuationAndTranslationAdjustmentsMember
80860
2024-04-01
2025-03-31
jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember
80860
2025-03-31
80860
2025-03-31
jppfs_cor:CapitalStockMember
80860
2025-03-31
jppfs_cor:CapitalSurplusMember
80860
2025-03-31
jppfs_cor:DeferredGainsOrLossesOnHedgesMember
80860
2025-03-31
jppfs_cor:ForeignCurrencyTranslationAdjustmentMember
80860
2025-03-31
jppfs_cor:NonControllingInterestsMember
80860
2025-03-31
jpcrp_cor:OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember
80860
2025-03-31
jpcrp_cor:ReconcilingItemsMember
80860
2025-03-31
jppfs_cor:RemeasurementsOfDefinedBenefitPlansMember
80860
2025-03-31
jpcrp_cor:ReportableSegmentsMember
80860
2025-03-31
jppfs_cor:RetainedEarningsMember
80860
2025-03-31
jppfs_cor:ShareholdersEquityMember
80860
2025-03-31
jppfs_cor:SubscriptionRightsToSharesMember
80860
2025-03-31
jpcrp_cor:TotalOfReportableSegmentsAndOthersMember
80860
2025-03-31
jppfs_cor:TreasuryStockMember
80860
2025-03-31
tse-acedjpfr-80860:MedicalTreatmentRelatedReportableSegmentsMember
80860
2025-03-31
tse-acedjpfr-80860:MedicineRelatedReportableSegmentsMember
80860
2025-03-31
tse-acedjpfr-80860:PharmaPackagingReportableSegmentMember
80860
2025-03-31
jppfs_cor:ValuationAndTranslationAdjustmentsMember
80860
2025-03-31
jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember
80860
2023-04-01
2024-03-31
80860
2023-04-01
2024-03-31
jppfs_cor:CapitalStockMember
80860
2023-04-01
2024-03-31
jppfs_cor:CapitalSurplusMember
80860
2023-04-01
2024-03-31
jppfs_cor:DeferredGainsOrLossesOnHedgesMember
80860
2023-04-01
2024-03-31
jppfs_cor:ForeignCurrencyTranslationAdjustmentMember
80860
2023-04-01
2024-03-31
jppfs_cor:NonControllingInterestsMember
80860
2023-04-01
2024-03-31
jpcrp_cor:OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember
80860
2023-04-01
2024-03-31
jpcrp_cor:ReconcilingItemsMember
80860
2023-04-01
2024-03-31
jppfs_cor:RemeasurementsOfDefinedBenefitPlansMember
80860
2023-04-01
2024-03-31
jpcrp_cor:ReportableSegmentsMember
80860
2023-04-01
2024-03-31
jppfs_cor:RetainedEarningsMember
80860
2023-04-01
2024-03-31
jppfs_cor:ShareholdersEquityMember
80860
2023-04-01
2024-03-31
jppfs_cor:SubscriptionRightsToSharesMember
80860
2023-04-01
2024-03-31
jpcrp_cor:TotalOfReportableSegmentsAndOthersMember
80860
2023-04-01
2024-03-31
jppfs_cor:TreasuryStockMember
80860
2023-04-01
2024-03-31
tse-acedjpfr-80860:MedicalTreatmentRelatedReportableSegmentsMember
80860
2023-04-01
2024-03-31
tse-acedjpfr-80860:MedicineRelatedReportableSegmentsMember
80860
2023-04-01
2024-03-31
tse-acedjpfr-80860:PharmaPackagingReportableSegmentMember
80860
2023-04-01
2024-03-31
jppfs_cor:ValuationAndTranslationAdjustmentsMember
80860
2023-04-01
2024-03-31
jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember
80860
2024-03-31
80860
2024-03-31
jppfs_cor:CapitalStockMember
80860
2024-03-31
jppfs_cor:CapitalSurplusMember
80860
2024-03-31
jppfs_cor:DeferredGainsOrLossesOnHedgesMember
80860
2024-03-31
jppfs_cor:ForeignCurrencyTranslationAdjustmentMember
80860
2024-03-31
jppfs_cor:NonControllingInterestsMember
80860
2024-03-31
jpcrp_cor:OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember
80860
2024-03-31
jpcrp_cor:ReconcilingItemsMember
80860
2024-03-31
jppfs_cor:RemeasurementsOfDefinedBenefitPlansMember
80860
2024-03-31
jpcrp_cor:ReportableSegmentsMember
80860
2024-03-31
jppfs_cor:RetainedEarningsMember
80860
2024-03-31
jppfs_cor:ShareholdersEquityMember
80860
2024-03-31
jppfs_cor:SubscriptionRightsToSharesMember
80860
2024-03-31
jpcrp_cor:TotalOfReportableSegmentsAndOthersMember
80860
2024-03-31
jppfs_cor:TreasuryStockMember
80860
2024-03-31
tse-acedjpfr-80860:MedicalTreatmentRelatedReportableSegmentsMember
80860
2024-03-31
tse-acedjpfr-80860:MedicineRelatedReportableSegmentsMember
80860
2024-03-31
tse-acedjpfr-80860:PharmaPackagingReportableSegmentMember
80860
2024-03-31
jppfs_cor:ValuationAndTranslationAdjustmentsMember
80860
2024-03-31
jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember
80860
2022-04-01
2023-03-31
80860
2022-04-01
2023-03-31
jppfs_cor:CapitalStockMember
80860
2022-04-01
2023-03-31
jppfs_cor:CapitalSurplusMember
80860
2022-04-01
2023-03-31
jppfs_cor:DeferredGainsOrLossesOnHedgesMember
80860
2022-04-01
2023-03-31
jppfs_cor:ForeignCurrencyTranslationAdjustmentMember
80860
2022-04-01
2023-03-31
jppfs_cor:NonControllingInterestsMember
80860
2022-04-01
2023-03-31
jppfs_cor:RemeasurementsOfDefinedBenefitPlansMember
80860
2022-04-01
2023-03-31
jppfs_cor:RetainedEarningsMember
80860
2022-04-01
2023-03-31
jppfs_cor:ShareholdersEquityMember
80860
2022-04-01
2023-03-31
jppfs_cor:SubscriptionRightsToSharesMember
80860
2022-04-01
2023-03-31
jppfs_cor:TreasuryStockMember
80860
2022-04-01
2023-03-31
jppfs_cor:ValuationAndTranslationAdjustmentsMember
80860
2022-04-01
2023-03-31
jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember
80860
2023-03-31
80860
2023-03-31
jppfs_cor:CapitalStockMember
80860
2023-03-31
jppfs_cor:CapitalSurplusMember
80860
2023-03-31
jppfs_cor:DeferredGainsOrLossesOnHedgesMember
80860
2023-03-31
jppfs_cor:ForeignCurrencyTranslationAdjustmentMember
80860
2023-03-31
jppfs_cor:NonControllingInterestsMember
80860
2023-03-31
jppfs_cor:RemeasurementsOfDefinedBenefitPlansMember
80860
2023-03-31
jppfs_cor:RetainedEarningsMember
80860
2023-03-31
jppfs_cor:ShareholdersEquityMember
80860
2023-03-31
jppfs_cor:SubscriptionRightsToSharesMember
80860
2023-03-31
jppfs_cor:TreasuryStockMember
80860
2023-03-31
jppfs_cor:ValuationAndTranslationAdjustmentsMember
80860
2023-03-31
jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember
iso4217:JPY
xbrli:pure